Earnings Feed
Start Free
Home/Filings/4/0001638599-17-000299
4//SEC Filing

AYTU BIOSCIENCE, INC 4

Accession 0001638599-17-000299

$AYTUCIK 0001385818operating
View on SEC.govCompany Profile

Filed

Mar 16, 8:00 PM ET

Accepted

Mar 17, 4:27 PM ET

Size

22.6 KB

Accession

0001638599-17-000299

Insider Transaction Report

Form 4
Period: 2017-03-16
AYTU BIOSCIENCE, INCAYTU
MACALUSO MICHAEL
Director
Transactions
  • Disposition to Issuer

    Stock Option Grant

    2017-03-16−22,500→ 0 total
    Exercise: $3.23Exp: 2026-07-07→ Common Stock (22,500 underlying)
  • Disposition to Issuer

    Stock Option Grant

    2017-03-16−8,334→ 0 total
    Exercise: $3.23From: 2016-04-11Exp: 2026-04-10→ Common Stock (8,334 underlying)
  • Award

    Stock Option Grant

    2017-03-16+8,334→ 8,334 total
    Exercise: $0.82From: 2016-04-11Exp: 2026-04-11→ Common Stock (8,334 underlying)
  • Award

    Stock Option Grant

    2017-03-16+22,500→ 22,500 total
    Exercise: $0.82Exp: 2026-07-07→ Common Stock (22,500 underlying)
  • Award

    Stock Option Grant

    2017-03-16+10,417→ 10,417 total
    Exercise: $0.82From: 2015-11-11Exp: 2025-11-11→ Common Stock (10,417 underlying)
  • Disposition to Issuer

    Stock Option Grant

    2017-03-16−10,417→ 0 total
    Exercise: $3.23From: 2015-11-11Exp: 2025-11-11→ Common Stock (10,417 underlying)
Holdings

  • Stock Option Grant

    Exercise: $18.12From: 2015-11-11Exp: 2025-11-11→ Common Stock (10,417 underlying)
    0

  • Stock Option Grant

    Exercise: $18.12From: 2015-11-11Exp: 2025-11-11→ Common Stock (10,417 underlying)
    10,417

  • Common Stock

    94,780

  • Stock Option Grant

    Exercise: $6.72From: 2016-04-11Exp: 2026-04-10→ Common Stock (8,334 underlying)
    0

  • Stock Option Grant

    Exercise: $6.72From: 2016-04-11Exp: 2026-04-10→ Common Stock (8,334 underlying)
    8,334
Footnotes (4)
  • [F1]These are restricted shares that vest on July 7, 2026, subject to earlier vesting in certain situations.
  • [F2]The number of shares has been decreased and the exercise price has been increased to reflect the twelve-for-one stock split effected on June 30, 2016.
  • [F3]These six transactions involved an amendment of the exercise price of an outstanding option, resulting in the deemed cancellation of the "old" option and the grant of a replacement option. These options are 100% vested.
  • [F4]25% vests on September 30, 2016, December 31, 2016, March 31, 2017 and June 30, 2017, subject to the Grantee's continued service as an employee on such dates.

Documents

1 file

Issuer

AYTU BIOSCIENCE, INC

CIK 0001385818

→
Entity typeoperating
IncorporatedDE

Related Parties

1
  • filerCIK 0001385818

Filing Metadata

Form type
4
Filed
Mar 16, 8:00 PM ET
Accepted
Mar 17, 4:27 PM ET
Size
22.6 KB
View on SEC.gov